NEWMarkets
ResMed (RMD) Stock Rises 3% Following RBC Upgrade to Outperform
Published on 9/15/2026
AI Summary
Summarized by AI from the source belowResMed (RMD) experienced a stock increase of 3% after RBC Capital upgraded its rating to Outperform. This upgrade signals a more favorable outlook for the company. The increased stock price reflects investor confidence influenced by the analyst's assessment. Such upgrades can often lead to increased buying interest, which may positively impact ResMed's market performance.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
